Induction chemotherapy with cetuximab, vinorelbine–cisplatin followed by thoracic radiotherapy and concurrent cetuximab, vinorelbine–cisplatin in patients with unresectable stage III non-small cell lung cancer-Reference-Cited by-同舟云学术

Induction chemotherapy with cetuximab, vinorelbine–cisplatin followed by thoracic radiotherapy and concurrent cetuximab, vinorelbine–cisplatin in patients with unresectable stage III non-small cell lung cancer

Published:2015-09 Issue:3 Volume:89 Page:249-254
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Liu Di,Zheng Xiao,Chen Jiayan,Liu Guan,Xu Yaping,Shen Yuxin,Xie Liyi,Zhao Weixin,Jiang Guoliang,Fan Min

Funder

Merck Serono Co. Ltd

National Project for Key Clinical Specialty Development

Chinese Ministry of Public Health, and Research

Science & Technology Commission of Shanghai Municipality

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference26 articles.

1. Global cancer statistics;Jemal;CA Cancer J Clin,2011

2. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003;Pfister;J Clin Oncol,2004

3. Cooperative group portfolio in locally advanced non-small-cell lung cancer: are we making progress;Langer;Clin Lung Cancer,2008

4. Eligibility for concurrent chemotherapy and radiotherapy of locally advanced lung cancer patients: a prospective, population-based study;De Ruysscher;Ann Oncol,2009

5. Concurrent chemoradiotherapy for large-volume locally-advanced non-small cell lung cancer;Wiersma;Lung Cancer,2013

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of EGFR inhibitors and radiotherapy in locally advanced non-small-cell lung cancer: a meta-analysis;Future Oncology;2022-09

2. Combining radiotherapy with targeted therapies in non-small cell lung cancer: focus on anti-EGFR, anti-ALK and anti-angiogenic agents;Translational Lung Cancer Research;2021-04

3. Cetuximab and Doxorubicin loaded dextran-coated Fe3O4 magnetic nanoparticles as novel targeted nanocarriers for non-small cell lung cancer;Journal of Magnetism and Magnetic Materials;2019-07

4. EGFR-directed monoclonal antibodies in combination with chemotherapy for treatment of non-small-cell lung cancer: an updated review of clinical trials and new perspectives in biomarkers analysis;Cancer Treatment Reviews;2019-01

5. Locally Advanced Non-small Cell Lung Cancer and Targeted Therapy;Molecular Targeted Therapy of Lung Cancer;2017